[4-(5-aminomethyl-2-fluoro-phenyl)-pipe ridin1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifl uoromethoxy-1H-indol-3-yl]-methanone as an inhibitor of mast cell tryptase

Details for Australian Patent Application No. 2009282884 (hide)

Owner Sanofi-Aventis

Inventors Choi-Sledeski, Yong Mi; Choy, Nakyen; Poli, Gregory Bernard; Shay Jr., John J.; Shum, Patrick Wai-Kwok; Sledeski, Adam W.

Agent Watermark

Pub. Number AU-A-2009282884

PCT Pub. Number WO2010/022196

Priority 61/091,018 22.08.08 US; 61/091,011 22.08.08 US

Filing date 20 August 2009

Wipo publication date 25 February 2010

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/404 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/022196 Priority application(s): WO2010/022196

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009282886-RCC Tcell receptors and related materials and methods of use

2009282880-Safety razor having pivotable blade unit